Tetrahydrocurcumin

Tetrahydrocurcumin is a curcuminoid, a member of the family of polyphenols derived from turmeric (Curcuma longa). It is the fully reduced, or hydrogenated, form of curcumin, in which the double bonds of the central chain have been saturated with hydrogen. This structural change strips away the intense yellow color of curcumin, leaving a compound that is white to off-white, and it improves the molecule's stability. Tetrahydrocurcumin can be prepared industrially by hydrogenating curcumin, and it also arises naturally in the body: after curcumin is eaten, enzymes in the liver and gut, together with intestinal microbes, convert much of it into reductive metabolites, of which tetrahydrocurcumin is a major one ^[1][4].

Interest in tetrahydrocurcumin stems largely from the well-known limitations of curcumin itself. Curcumin has attracted attention for a broad range of biological activities, but its usefulness is constrained by poor absorption, rapid metabolism, and low concentrations in the blood. As a principal active metabolite, tetrahydrocurcumin is reported to have greater stability and higher bioavailability than curcumin, part of why researchers have examined it as a compound in its own right ^[1]. Pharmacokinetic studies in animals have tracked how curcumin and tetrahydrocurcumin distribute across tissues such as the liver and intestine, with tetrahydrocurcumin appearing abundantly in the gut and liver ^[4].

Laboratory and animal research has explored tetrahydrocurcumin across a range of conditions, including metabolic problems, kidney and cardiovascular injury, inflammatory disease, neurological disorders, and cancer models, with reported effects tied to its antioxidant and anti-inflammatory actions ^[1]. For instance, in a rat model of diabetic kidney disease, adding tetrahydrocurcumin to standard blood-pressure treatment raised antioxidant defenses, reduced markers of kidney injury and scarring, and lowered blood pressure ^[2]. Other work has combined tetrahydrocurcumin with zinc or other carriers in an effort to further improve absorption and antioxidant capacity and to modulate inflammatory signaling molecules ^[3]. These findings are preclinical, and rigorous human clinical trials remain limited.

Tetrahydrocurcumin is sold as a dietary supplement and used as an ingredient in skincare and cosmetic products, where it is valued as an antioxidant and, in some formulations, for effects on skin tone. In these settings it is regulated as a supplement or cosmetic ingredient rather than as an approved drug, so claims about disease prevention or treatment are not established medical uses. Its safety profile in humans is not as thoroughly characterized as that of curcumin, and available reviews note the need for more pharmacokinetic and toxicology data to support wider use ^[1].

Considered well tolerated with a safety profile similar to curcumin. High doses may cause mild GI upset. Human safety data are more limited than for standard curcumin. It can theoretically affect drug metabolism, so caution with medications.